Given the importance of TGF-β signaling in bone remodeling, particularly as a coupling factor between resorption and formation, it is not surprising that members of the TGF-β family are also implicated in metabolic bone diseases (osteoporosis) or bone malignancies (metastases, multiple myeloma). This evidence concerns the gene TGFB1 and osteoporosis.